vaxinpad

vaxinpad predicts immunomodulatory A-cell epitopes to facilitate design of peptide-based vaccine adjuvants that modulate antigen-presenting cells (APCs).

Key Features:

• A-Cell Epitope Prediction: Identifies A-cell epitopes—peptides that activate antigen-presenting cells (APCs) and potentially function as immunostimulatory vaccine adjuvants.
• Machine Learning Models: Employs support vector machine (SVM)-based models using sequence-based features, including dipeptide composition and motif occurrence.
• High Predictive Accuracy: A hybrid model achieved 95.71% accuracy and Matthews correlation coefficient (MCC) 0.91 on the training dataset and 95.00% accuracy and MCC 0.90 on independent datasets.

Scientific Applications:

• Vaccine adjuvant design: Enables selection and design of peptide candidates for developing peptide-based vaccine adjuvants by predicting A-cell epitopes.
• Immunology and vaccinology research: Supports studies of APC-targeting immunomodulatory peptides to enhance immune responses and inform immunization strategies.

Methodology:

Compiled a dataset of experimentally validated A-cell epitopes, extracted sequence-based features (including dipeptide composition and motif occurrence), trained SVM-based machine learning models, and evaluated performance on independent datasets.